MOLN

Molecular Partners AG American Depositary Shares (MOLN)

NASDAQ: MOLNUSD
3.85 USD
-0.16 (-3.87%)
AT CLOSE (11:59 AM EDT)
4.11
+0.36 (+9.22%)
POST MARKET (AS OF 06:05 PM EDT)
🟢Market: OPEN
Open?$3.87
High?$4.07
Low?$3.84
Prev. Close?$4.01
Volume?3.3K
Avg. Volume?N/A
VWAP?$4.10
Bid / Ask
Bid?$3.87 × 100
Ask?$4.36 × 100
Spread?$0.49
Midpoint?$4.12
Valuation & Ratios
Market Cap?149.8M
Shares Out?40.4M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Employees
134
Market Cap
149.8M
Industry
N/A
Listed
2021-06-16